On December 20, Eastern Time, the five-day Arm and Qualcomm dispute came to an end. The jury made a ruling and supported Qualcomm on key issues, saying that Qualcomm provided superior evidence to prove that CPU research and development, including the acquisition of Nuvia's patents, complied with its ALA agreement. At the same time, Arm failed to fully prove that Qualcomm violated Nuvia's ALA agreement. Although the jury tended to support Qualcomm in its ruling, they have not yet ruled on whether Nuvia violated its ALA agreement. This means that Qualcomm uses Nuvia technology for chip research and development, which complies with the ALA agreement signed between the company and Arm, and can continue to sell its self-developed chip products to customers. It is reported that the ALA agreement is one of Arm's two licensing methods, which means that manufacturers purchase Arm instruction sets for independent research and development of chip cores, which is more free than the TLA agreement (another licensing method of Arm). After the ruling, Qualcomm issued an official statement saying that we are satisfied with today's ruling. All Qualcomm products involved in this case are protected by Qualcomm and Arm contracts. We will continue to develop custom CPUs including Oryon Arm compatibility.